You searched for "treatment"

864 results found

Upper tract urothelial carcinoma following cystectomy

Metachronous upper tract urothelial cancer (UTUC) is encountered in about 5% of patients after radical cystectomy (RC) with a median time to diagnosis of 24-36 months after RC, and most are asymptomatic and detected by surveillance protocols. In this multivariate...

Botox® instillation into the bladder

Patients with refractory overactive bladder (OAB) may be offered OnabotulinumtoxinA (Botox®) as one of the third-line options. Given the invasive nature of requiring cystoscopy, injections via a needle and local anaesthesia, it would be simpler, more convenient and more accessible...

SNNLive caught up with Andrew Tasker, CEO of Femeda Ltd.

SNNLive spoke with Andrew Tasker, CEO of Femeda Ltd. at the Planet MicroCap Showcase 2019 in Las Vegas, NV, and they discuss the following topics: Overview and history of Femeda, Update since our last interview...

Bladder & Bowel UK National Symposium North West

The Bladder & Bowel UK National Symposium North West 2026 Supporting bladder and bowel health for everyone Join us at the Bladder & Bowel UK North West Symposium! This is an exceptional opportunity for healthcare professionals to engage with leading...

Exciting opportunity for a Full time Band 7 Urology Nurse Specialist

An exciting opportunity has arisen for a Full time Band 7 Urology Nurse Specialist to join The Birmingham Prostate Specialists Service in conjunction with HCA Harborne Hospital, Birmingham. (Part time would be considered) The post holder will be initially supported...

Bladder & Bowel UK Symposium in the North

Supporting bladder and bowel health for everyone Join us at the Bladder & Bowel UK North West Symposium! This is an exceptional opportunity for healthcare professionals to engage with leading national experts and immerse themselves in a programme packed with...

What is the role of evidence-based medicine in urology?

The concept of ‘evidence-based medicine’ (EBM) was first developed in the early 1990s and was described as “the conscientious, explicit and judicious use of the current best evidence in making decisions about the care of individual patients” by the recently...

Emphysematous pyelonephritis: a review

Introduction Emphysematous pyelonephritis (EPN) is an acute, severe, necrotising, bacterial infection of the renal parenchyma and surrounding tissues, with gas in the renal parenchyma, collecting system or perinephric tissue. Although it is rare, it is potentially life threatening and early...

Patient portals

In May 2012, the Department of Health published its information strategy ‘Power of information’ which aims to put us all in control of the health and care information we need [1]. As a part of its information strategy a key...

Blaedderwaerc and other names

In this series of articles I am going to show you some of the exhibits contained in the Museum of Urology, hosted on the BAUS website (www.baus.org.uk). In the last article I said I would explore the history of something...

Urolithiasis – metabolic considerations

Case 1 A 32-year-old female patient is diagnosed with a ureteric calculus for the first-time. What type of metabolic evaluation investigations should be performed? When should stone analysis be repeated? What are the most common metabolic abnormalities associated with calcium...

ICS (International Continence Society) 2024

Each year, the International Continence Society hosts its annual meeting bringing together healthcare professionals interested in treating incontinence patients. Attendees can benefit from the latest research, professional development and networking opportunities. It provides a platform to exchange ideas and share best practices. Leading experts in the field also present workshops and state of the art sessions.